Cartesian Therapeutics (RNAC) Return on Sales (2015 - 2026)
Cartesian Therapeutics (RNAC) posted quarterly Return on Sales of 3.42% for Q1 2026, down 323.0% year-over-year from 1.53% in Q1 2025, and down 312.02% quarter-over-quarter from 0.83% in Q4 2025.
Cartesian Therapeutics (RNAC) Return on Sales (2015 - 2026) Analysis & Trends
Cartesian Therapeutics (RNAC) has reported Return on Sales for 12 consecutive years, with 3.42% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Sales fell 323.0% year-over-year to 3.42%; the TTM figure through Mar 2026 stood at 1.63% (down 160.0% YoY), while the FY2025 annual figure was 0.47%, down 45.0% from the prior year.
- Return on Sales declined to 3.42% in Q1 2026 per RNAC's latest filing, from 0.83% in the prior quarter.
- Across five years, Return on Sales topped out at 0.3% in Q4 2024 and bottomed at 4.27% in Q2 2025.
- Historically, Return on Sales has averaged 0.76% across 5 years, with a median of 0.03% in 2023.
- Annual changes were most pronounced in 2024 — Return on Sales surged 54 bps — and 2025, when it tumbled 427 bps.
- Cartesian Therapeutics' Return on Sales stood at 0.0% in 2022, then slumped by 6880 bps to 0.24% in 2023, then jumped by 227 bps to 0.3% in 2024, then slumped by 374 bps to 0.83% in 2025, then sank by 312 bps to 3.42% in 2026.
- Business Quant data shows RNAC's Return on Sales at 3.42% in Q1 2026, 0.83% in Q4 2025, and 4.06% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 0.00% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.00% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.00% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.00% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.00% |
| 10 | Cartesian Therapeutics | 265.54 Mn | 265.54 Mn | - | -1.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.33% |
| Mar 31, 2026 | -3.42% |
| Dec 31, 2025 | -0.83% |
| Sep 30, 2025 | -4.06% |
| Jun 30, 2025 | -4.27% |
| Mar 31, 2025 | -0.18% |
| Dec 31, 2024 | 0.30% |
| Sep 30, 2024 | -0.06% |
| Jun 30, 2024 | -0.01% |
| Mar 31, 2024 | -0.04% |
| Dec 31, 2023 | -0.24% |
| Sep 30, 2023 | -0.01% |
| Jun 30, 2023 | -0.03% |
| Mar 31, 2023 | -0.03% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | -0.01% |